[Experience with movalis administration against osteoarthritis in Moscow clinics].
OBJECTIVE
To test effectiveness of a new nonsteroid antiinflammatory drug movalis in osteoarthritis.


METHODS
113 patients aged 30-85 years from 8 Moscow clinics were treated with movalis. All the patients had long-standing osteoarthritis, 26 patients had concomitant gastric or duodenal ulcers. Movalis was given in daily dose from 7.5 to 15 mg for 1-4 weeks.


RESULTS
None case of ulcer onset or recurrence was observed. The response was rated as good in 44.2, satisfactory in 47.0% and bad in 8.8% of the cases. Tolerance was good in 99.1% of patients and bad in 0.9%.


CONCLUSIONS
Movalis has a definite antiinflammatory and analgetic activity in patients with osteoarthritis and spondylarthrosis.
Kogan
K M
KM
Zolotareva
G D
GD
Shmidt
E I
EI
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007527:Isoenzymes / Q000037:antagonists & inhibitors*; D008297:Male; D000077239:Meloxicam; D008875:Middle Aged; D009031:Moscow; D010003:Osteoarthritis / Q000188:drug therapy*; D010147:Pain Measurement; D012189:Retrospective Studies; D013843:Thiazines / Q000008:administration & dosage* / Q000627:therapeutic use; D013844:Thiazoles / Q000008:administration & dosage* / Q000627:therapeutic use; D016896:Treatment Outcome
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007527:Isoenzymes; D013843:Thiazines; D013844:Thiazoles; D000077239:Meloxicam